We must consider the full spectrum of patients culture, trauma, mental health, structural advantages and disadvantages, lifestyle, and economic resources when considering which medications can effectively address their addiction in a long-term, sustainable way that benefits overall health and restores agency
sometimes the peptide dosing is as straightforward as a reduced dose per administration, but we must involve specialists
For additional perspective, heres a list of more studies that show the same: A potential link between liraglutide and thyroid cancer (along with pancreatic and gallbladder problems as well) (3) Study highlighting that liraglutide should not be used in people with a family history of medullary thyroid cancer (4) A study showing there is no increase in the risk of thyroid cancer (for additional perspective) (5) A meta-analysis showing that there is not enough evidence to suggest there is a link between thyroid cancer and GLP-1 agonists (6) Its worth pointing out that while there is still debate on this topic, the larger and bigger studies on this issue seem to support a connection between the two
Some GLP-1 analogs use recombinant fermentation processes
Moreover, optimal therapeutic strategies to concurrently address obesity-related cardiovascular and metabolic comorbidities, including hypertension and dyslipidemia, are lacking